Moxifloxacin Hydrochloride/Dexamethasone Sodium Phosphate

盐酸莫西沙星/地塞米松磷酸钠

Report date: 2025/11/14 14:12:26

Base Information

Drug NameMoxifloxacin Hydrochloride/Dexamethasone Sodium Phosphate
Drug Alias NameOT-601-C滴眼液OT-601-C
ClassificationSmall molecules > Steroids
Mechanisms of ActionBacterial DNA gyrase inhibitorsTopoisomerase IV inhibitorsGlucocorticoid receptor agonists
TargetsTopoisomerase IVBacterial DNA gyraseGlucocorticoid receptor
Therapy Area/IndicationsInflammationBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Moxifloxacin HydrochlorideDexamethasone Sodium Phosphate
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesOcumension Therapeutics (Suzhou) Co LtdHangzhou Minsheng Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesOcumension Therapeutics (Suzhou) Co LtdHangzhou Minsheng Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsInflammationBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A